Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

Nature

Volumn 413, Issue 6852, 2001, Pages 165-171

  Diefenbach, Andreas ^a   Jensen, Eric R ^a   Jamieson, Amanda M ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; CELLS; TUMORS; VACCINES;

ANTI-TUMOR IMMUNITY;

BIOMEDICAL ENGINEERING;

CELL RECEPTOR; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN H60; PROTEIN RAE1; TUMOR VACCINE; UNCLASSIFIED DRUG;

MEDICINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T CELL LYMPHOMA; THYMOMA; TUMOR CELL LINE; TUMOR IMMUNITY; TUMOR REJECTION; VACCINATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; IMMUNITY; KILLER CELLS, NATURAL; LIGANDS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0035855872     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35093109     Document Type: Article

References (30)

1. Biology, of natural killer cells
2. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
3. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity
4. Decreased tumor surveillance in perforin-deficient mice
5. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice
6. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
7. In vivo natural killer cell activities revealed by natural killer cell-deficient mice
8. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells
9. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells
10. An activating immunoreceptor complex formed by NKG2D and DAP10
11. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
12. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible M1CA
13. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
14. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
15. Genomic structures and characterization of Rae1 family members encoding GP1-anchored cell surface proteins and expressed predominantly in embryonic mouse brain
16. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of M1CA and MICB
17. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin
18. Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin
19. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
20. Innate and adaptive immunity to tumors: IL-12 is required for optimal responses
21. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
22. Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
23. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: An adaptive component of NK call-mediated responses
24. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
25. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
26. Innate immunity: The virtues ora nonclonal system of recognition
27. The selection and characterization of an invasive variant of the B16 melanoma
28. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
29. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
30. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection